Fig 1.
Diagram flow of the clinical sample collection.
*PROM: Premature Rupture of Membranes; **pPROM: preterm PROM.
Table 1.
Prevalence of Escherichia coli among vaginal samples from pregnant women with normal gestation (A) and some risks at birth (B).
Fig 2.
Distribution of antimicrobial resistance among VEC and obstetric IEC isolates.
VEC isolates: vaginal Escherichia coli isolates; Obstetric IEC isolates: obstetric infection Escherichia coli isolates. AMP, ampicillin; AMC, amoxicillin/clavulanic acid; CXM, cefuroxime, CTX, cefotaxime; CAZ, ceftazidime; IPM, imipenem; TET, tetracycline, SXT, trimethoprim/ sulfamethoxazole; AMK, amikacin; GEN, gentamicin; CHL, chloramphenicol; CIP, ciprofloxacin and FOF, fosfomycin. (**p-value = 0.001).
Table 2.
Prevalence of virulence factor genes (VFGs) according to the type of isolate.
Fig 3.
Distribution of phylogenetic groups among the isolates.
Table 3.
Prevalence of virulence factor genes (VFGs) among the phylogenetic groups and the type of isolates according to their ampicillin resistance.